Triple-Therapy Alternatives · FDA-Sourced
Trelegy Ellipta Alternatives and Breztri Comparison
Trelegy Ellipta and Breztri Aerosphere are single-inhaler ICS/LAMA/LABA maintenance therapies with labeled asthma and COPD uses. They contain different active ingredients and use different devices, strengths, inhalations per dose, and schedules. Breztri is a same-class alternative, not a generic or dose-equivalent substitute for Trelegy.
Same-Class Alternative
Trelegy Ellipta compared with Breztri Aerosphere
Both are single-inhaler ICS/LAMA/LABA maintenance therapies with labeled asthma and COPD uses. Their shared class does not make their ingredients, strengths, devices, or doses interchangeable.
Starting Product
Trelegy Ellipta
Fluticasone Furoate/Umeclidinium/Vilanterol
- Device
- Dry Powder Inhaler
- Labeled Schedule
- 1 Inhalation Once Daily
Same-Class Option
Breztri Aerosphere
Budesonide/Glycopyrrolate/Formoterol
- Device
- Pressurized Metered Dose Inhaler
- Labeled Schedule
- 2 Inhalations Twice Daily
Trelegy Ellipta and Breztri Aerosphere are single-inhaler ICS/LAMA/LABA maintenance therapies with labeled asthma and COPD uses. They contain different active ingredients and differ in device, strength expression, inhalations per dose, and dosing schedule.
Trelegy Ellipta contains fluticasone furoate/umeclidinium/vilanterol in a dry-powder inhaler used once daily. Breztri Aerosphere contains budesonide/glycopyrrolate/formoterol in a pressurized metered-dose inhaler used as 2 inhalations twice daily. Their microgram strengths cannot be compared or converted ingredient-for-ingredient.
Breztri Aerosphere is a same-class triple-therapy alternative, not an FDA therapeutic equivalent or dose conversion for Trelegy Ellipta. Do not switch products, strengths, devices, or schedules without prescriber or pharmacist guidance.
Condition-Specific Labeling
Asthma and COPD use different product-specific regimens
The strengths below come from each product label. Rows in the same condition are comparisons only; they are not dose conversions.
COPD Maintenance · Adults
COPD-Labeled Regimens
- Trelegy Ellipta
- 100/62.5/25 mcg — 1 inhalation once daily
- Breztri Aerosphere
- 160/9/4.8 mcg per inhalation — 2 inhalations twice daily
Asthma Maintenance
Asthma-Labeled Regimens
- Trelegy Ellipta · Adults 18+
- 100/62.5/25 or 200/62.5/25 mcg — 1 inhalation once daily
- Breztri Aerosphere · Ages 12+
- 160/18/4.8 mcg per inhalation — 2 inhalations twice daily
No direct generic match displayed
Trelegy Ellipta did not appear in the FDA authorized-generics listing reviewed for this page. Breztri is a different brand-name triple-therapy product—not a Trelegy generic.
Technique changes with the device
Trelegy is a dry-powder inhaler; Breztri is a pressurized metered-dose inhaler. A switch changes both the dosing schedule and inhalation technique, so device counseling remains part of safe prescribing and dispensing.
Common Questions
Trelegy Ellipta and Breztri Aerosphere FAQ
Is Breztri Aerosphere equivalent to Trelegy Ellipta?
No. Trelegy Ellipta and Breztri Aerosphere are both ICS/LAMA/LABA maintenance inhalers, but they contain different active ingredients and use different devices, strength expressions, inhalations per dose, and schedules. Breztri is a same-class alternative, not an FDA therapeutic equivalent or dose conversion for Trelegy.
What is the difference between Trelegy Ellipta and Breztri Aerosphere?
Trelegy contains fluticasone furoate, umeclidinium, and vilanterol in a dry-powder inhaler taken as 1 inhalation once daily. Breztri contains budesonide, glycopyrrolate, and formoterol in a pressurized metered-dose inhaler taken as 2 inhalations twice daily. The products also use condition-specific strengths and have different device instructions.
Which Trelegy Ellipta strength is labeled for COPD?
Trelegy Ellipta 100/62.5/25 mcg is the only strength labeled for COPD maintenance treatment. The 200/62.5/25 mcg strength is labeled for adult asthma and is not presented as a COPD regimen on this page.
Can Trelegy Ellipta and Breztri Aerosphere both be used for asthma?
Both have labeled asthma maintenance uses, but their populations and regimens differ. Trelegy Ellipta labeling used here covers adults aged 18 years and older at 100/62.5/25 mcg or 200/62.5/25 mcg once daily. Breztri labeling covers patients aged 12 years and older at 160/18/4.8 mcg per inhalation, administered as 2 inhalations twice daily.
Does Trelegy Ellipta have an FDA-listed authorized generic?
Trelegy Ellipta does not appear in the FDA authorized-generics listing reviewed for this page on August 28, 2026. Breztri Aerosphere is not a Trelegy generic; it is a separate brand-name triple-therapy inhaler with different active ingredients and dosing instructions. Availability can change, so confirm current products with a pharmacist or FDA source.
Can I switch between Trelegy Ellipta and Breztri Aerosphere on my own?
No. A prescriber or pharmacist should confirm the indication, strength, dosing schedule, insurance coverage, contraindications, and device technique before a switch. Neither product should be used as a rescue inhaler for sudden symptoms.
Primary Sources
Evidence used for this page
DailyMed / U.S. National Library of Medicine
BREZTRI AEROSPHERE Prescribing Information
Supports Breztri Aerosphere ingredients, condition-specific strengths, metered-dose device, twice-daily schedule, asthma and COPD populations, and limitations.
DailyMed / U.S. National Library of Medicine
TRELEGY ELLIPTA Prescribing Information
Supports Trelegy Ellipta ingredients, strengths, dry-powder device, once-daily schedule, adult asthma and COPD indications, and limitations.
U.S. Food and Drug Administration
FDA List of Authorized Generic Drugs
Explains what an FDA authorized generic is and how it differs from a conventional generic.
U.S. Food and Drug Administration
FDA Listing of Authorized Generics
Current FDA authorized-generics listing reviewed for whether Trelegy Ellipta appears as a listed product.
Reviewed by PulmTools Editorial Review on August 28, 2026.
Explore respiratory pharmacology →